FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
Source: www.npr.org ·
Section: headlines ·
Bias: Center-Left
· Published: Sat, 01 Aug 2026 11:00:00 GMT
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.
Read the full article at www.npr.org →
The same story across the political spectrum (1 sources)
← Back to FlashTopics.com